APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Ophthalmic Drug Delivery Device

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Ophthalmic Drug Delivery Device Market Analysis and Forecast 2026-2032

Report ID 17442735045 July 2026200 pages

Choose your research edition.

Industry ResearchOphthalmic Drug Delivery Device Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Ophthalmic Drug Delivery Device Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Ophthalmic Drug Delivery Device Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Ophthalmic Drug Delivery Device Market Outlook and Growth Opportunities 2026209 pages · $4,250 USDMarket Analysis & ForecastGlobal Ophthalmic Drug Delivery Device Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Ophthalmic Drug Delivery Device market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Ophthalmic Drug Delivery Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Ophthalmic Drug Delivery Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Ophthalmic Drug Delivery Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Ophthalmic Drug Delivery Device is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Ophthalmic Drug Delivery Device include West Pharmaceutical Services, Inc., Terumo Corporation, Silgan Holdings Inc., Re-Vana Therapeutics, Owen Mumford, Ocumedic, Inc., Ocular Therapeutix, Nipro Corporation and Nemera, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Ophthalmic Drug Delivery Device, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Ophthalmic Drug Delivery Device, also provides the sales of main regions and countries. Of the upcoming market potential for Ophthalmic Drug Delivery Device, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Ophthalmic Drug Delivery Device sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Ophthalmic Drug Delivery Device market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Ophthalmic Drug Delivery Device sales, projected growth trends, production technology, application and end-user industry.

Ophthalmic Drug Delivery Device Segment by Company

West Pharmaceutical Services, Inc.

Terumo Corporation

Silgan Holdings Inc.

Re-Vana Therapeutics

Owen Mumford

Ocumedic, Inc.

Ocular Therapeutix

Nipro Corporation

Nemera

Mati Therapeutics, Inc.,

Kedalion Therapeutics

Gerresheimer

Gaplast GmbH

EyePoint Pharmaceuticals, Inc.

Biocorp Production

Becton Dickinson & Company

Bausch Health

AptarGroup

Aero Pump GmbH

Ophthalmic Drug Delivery Device Segment by Type

Multidose Eyedroppers

Add-On Devices

Squeeze Dispenser

Mist Sprayers

Contact Lenses

Pre-Filled Syringes

Others

Ophthalmic Drug Delivery Device Segment by Application

Clinics

Hospitals

Homecare

Others

Ophthalmic Drug Delivery Device Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Ophthalmic Drug Delivery Device market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Ophthalmic Drug Delivery Device and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Ophthalmic Drug Delivery Device.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Ophthalmic Drug Delivery Device in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Ophthalmic Drug Delivery Device manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Ophthalmic Drug Delivery Device sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Ophthalmic Drug Delivery Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Multidose Eyedroppers Major Manufacturers Table 3. Add-On Devices Major Manufacturers Table 4. Squeeze Dispenser Major Manufacturers Table 5. Mist Sprayers Major Manufacturers Table 6. Contact Lenses Major Manufacturers Table 7. Pre-Filled Syringes Major Manufacturers Table 8. Others Major Manufacturers Table 9. Global Ophthalmic Drug Delivery Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 10. Clinics Major Manufacturers Table 11. Hospitals Major Manufacturers Table 12. Homecare Major Manufacturers Table 13. Others Major Manufacturers Table 14. Ophthalmic Drug Delivery Device Industry Trends Table 15. Ophthalmic Drug Delivery Device Industry Drivers Table 16. Ophthalmic Drug Delivery Device Industry Opportunities and Challenges Table 17. Ophthalmic Drug Delivery Device Industry Restraints Table 18. Global Ophthalmic Drug Delivery Device Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Ophthalmic Drug Delivery Device Revenue by Region (2021-2026) & (US$ Million) Table 20. Global Ophthalmic Drug Delivery Device Revenue by Region (2027-2032) & (US$ Million) Table 21. Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2021-2026) Table 22. Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2027-2032) Table 23. Global Ophthalmic Drug Delivery Device Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 24. Global Ophthalmic Drug Delivery Device Sales by Region (2021-2026) & (k units) Table 25. Global Ophthalmic Drug Delivery Device Sales by Region (2027-2032) & (k units) Table 26. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2021-2026) Table 27. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2027-2032) Table 28. Global Ophthalmic Drug Delivery Device Revenue by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Ophthalmic Drug Delivery Device Revenue Market Share by Manufacturers (2021-2026) Table 30. Global Ophthalmic Drug Delivery Device Sales by Manufacturers (US$ Million) & (2021-2026) Table 31. Global Ophthalmic Drug Delivery Device Sales Market Share by Manufacturers (2021-2026) Table 32. Global Ophthalmic Drug Delivery Device Sales Price (USD/unit) of Manufacturers (2021-2026) Table 33. Global Ophthalmic Drug Delivery Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 34. Global Ophthalmic Drug Delivery Device Key Manufacturers Manufacturing Sites & Headquarters Table 35. Global Ophthalmic Drug Delivery Device Manufacturers, Product Type & Application Table 36. Global Ophthalmic Drug Delivery Device Manufacturers' Establishment Date Table 37. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 38. Global Ophthalmic Drug Delivery Device by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Ophthalmic Drug Delivery Device Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Ophthalmic Drug Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 41. Global Ophthalmic Drug Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 42. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2021-2026) Table 43. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2027-2032) Table 44. Global Ophthalmic Drug Delivery Device Sales by Type 2021 VS 2025 VS 2032 (k units) Table 45. Global Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 46. Global Ophthalmic Drug Delivery Device Sales by Type (2027-2032) & (k units) Table 47. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2021-2026) Table 48. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2027-2032) Table 49. Global Ophthalmic Drug Delivery Device Price by Type (2021-2026) & (USD/unit) Table 50. Global Ophthalmic Drug Delivery Device Price by Type (2027-2032) & (USD/unit) Table 51. Global Ophthalmic Drug Delivery Device Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Ophthalmic Drug Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 53. Global Ophthalmic Drug Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 54. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2021-2026) Table 55. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2027-2032) Table 56. Global Ophthalmic Drug Delivery Device Sales by Application 2021 VS 2025 VS 2032 (k units) Table 57. Global Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 58. Global Ophthalmic Drug Delivery Device Sales by Application (2027-2032) & (k units) Table 59. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2021-2026) Table 60. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2027-2032) Table 61. Global Ophthalmic Drug Delivery Device Price by Application (2021-2026) & (USD/unit) Table 62. Global Ophthalmic Drug Delivery Device Price by Application (2027-2032) & (USD/unit) Table 63. West Pharmaceutical Services, Inc. Company Information Table 64. West Pharmaceutical Services, Inc. Business Overview Table 65. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 66. West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 67. West Pharmaceutical Services, Inc. Recent Development Table 68. Terumo Corporation Company Information Table 69. Terumo Corporation Business Overview Table 70. Terumo Corporation Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolio Table 72. Terumo Corporation Recent Development Table 73. Silgan Holdings Inc. Company Information Table 74. Silgan Holdings Inc. Business Overview Table 75. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 77. Silgan Holdings Inc. Recent Development Table 78. Re-Vana Therapeutics Company Information Table 79. Re-Vana Therapeutics Business Overview Table 80. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolio Table 82. Re-Vana Therapeutics Recent Development Table 83. Owen Mumford Company Information Table 84. Owen Mumford Business Overview Table 85. Owen Mumford Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Owen Mumford Ophthalmic Drug Delivery Device Product Portfolio Table 87. Owen Mumford Recent Development Table 88. Ocumedic, Inc. Company Information Table 89. Ocumedic, Inc. Business Overview Table 90. Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 92. Ocumedic, Inc. Recent Development Table 93. Ocular Therapeutix Company Information Table 94. Ocular Therapeutix Business Overview Table 95. Ocular Therapeutix Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolio Table 97. Ocular Therapeutix Recent Development Table 98. Nipro Corporation Company Information Table 99. Nipro Corporation Business Overview Table 100. Nipro Corporation Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolio Table 102. Nipro Corporation Recent Development Table 103. Nemera Company Information Table 104. Nemera Business Overview Table 105. Nemera Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Nemera Ophthalmic Drug Delivery Device Product Portfolio Table 107. Nemera Recent Development Table 108. Mati Therapeutics, Inc., Company Information Table 109. Mati Therapeutics, Inc., Business Overview Table 110. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolio Table 112. Mati Therapeutics, Inc., Recent Development Table 113. Kedalion Therapeutics Company Information Table 114. Kedalion Therapeutics Business Overview Table 115. Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolio Table 117. Kedalion Therapeutics Recent Development Table 118. Gerresheimer Company Information Table 119. Gerresheimer Business Overview Table 120. Gerresheimer Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Gerresheimer Ophthalmic Drug Delivery Device Product Portfolio Table 122. Gerresheimer Recent Development Table 123. Gaplast GmbH Company Information Table 124. Gaplast GmbH Business Overview Table 125. Gaplast GmbH Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolio Table 127. Gaplast GmbH Recent Development Table 128. EyePoint Pharmaceuticals, Inc. Company Information Table 129. EyePoint Pharmaceuticals, Inc. Business Overview Table 130. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 131. EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolio Table 132. EyePoint Pharmaceuticals, Inc. Recent Development Table 133. Biocorp Production Company Information Table 134. Biocorp Production Business Overview Table 135. Biocorp Production Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 136. Biocorp Production Ophthalmic Drug Delivery Device Product Portfolio Table 137. Biocorp Production Recent Development Table 138. Becton Dickinson & Company Company Information Table 139. Becton Dickinson & Company Business Overview Table 140. Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 141. Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolio Table 142. Becton Dickinson & Company Recent Development Table 143. Bausch Health Company Information Table 144. Bausch Health Business Overview Table 145. Bausch Health Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 146. Bausch Health Ophthalmic Drug Delivery Device Product Portfolio Table 147. Bausch Health Recent Development Table 148. AptarGroup Company Information Table 149. AptarGroup Business Overview Table 150. AptarGroup Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 151. AptarGroup Ophthalmic Drug Delivery Device Product Portfolio Table 152. AptarGroup Recent Development Table 153. Aero Pump GmbH Company Information Table 154. Aero Pump GmbH Business Overview Table 155. Aero Pump GmbH Ophthalmic Drug Delivery Device Sales (k units), Revenue (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 156. Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolio Table 157. Aero Pump GmbH Recent Development Table 158. North America Ophthalmic Drug Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 159. North America Ophthalmic Drug Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 160. North America Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 161. North America Ophthalmic Drug Delivery Device Sales by Type (2027-2032) & (k units) Table 162. North America Ophthalmic Drug Delivery Device Sales Price by Type (2021-2026) & (USD/unit) Table 163. North America Ophthalmic Drug Delivery Device Sales Price by Type (2027-2032) & (USD/unit) Table 164. North America Ophthalmic Drug Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 165. North America Ophthalmic Drug Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 166. North America Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 167. North America Ophthalmic Drug Delivery Device Sales by Application (2027-2032) & (k units) Table 168. North America Ophthalmic Drug Delivery Device Sales Price by Application (2021-2026) & (USD/unit) Table 169. North America Ophthalmic Drug Delivery Device Sales Price by Application (2027-2032) & (USD/unit) Table 170. North America Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 171. North America Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 172. North America Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 173. North America Ophthalmic Drug Delivery Device Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 174. North America Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units) Table 175. North America Ophthalmic Drug Delivery Device Sales by Country (2027-2032) & (k units) Table 176. North America Ophthalmic Drug Delivery Device Sales Price by Country (2021-2026) & (USD/unit) Table 177. North America Ophthalmic Drug Delivery Device Sales Price by Country (2027-2032) & (USD/unit) Table 178. United States Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 179. Canada Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 180. Mexico Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 181. Europe Ophthalmic Drug Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 182. Europe Ophthalmic Drug Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 183. Europe Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 184. Europe Ophthalmic Drug Delivery Device Sales by Type (2027-2032) & (k units) Table 185. Europe Ophthalmic Drug Delivery Device Sales Price by Type (2021-2026) & (USD/unit) Table 186. Europe Ophthalmic Drug Delivery Device Sales Price by Type (2027-2032) & (USD/unit) Table 187. Europe Ophthalmic Drug Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 188. Europe Ophthalmic Drug Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 189. Europe Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 190. Europe Ophthalmic Drug Delivery Device Sales by Application (2027-2032) & (k units) Table 191. Europe Ophthalmic Drug Delivery Device Sales Price by Application (2021-2026) & (USD/unit) Table 192. Europe Ophthalmic Drug Delivery Device Sales Price by Application (2027-2032) & (USD/unit) Table 193. Europe Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 194. Europe Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 195. Europe Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 196. Europe Ophthalmic Drug Delivery Device Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 197. Europe Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units) Table 198. Europe Ophthalmic Drug Delivery Device Sales by Country (2027-2032) & (k units) Table 199. Europe Ophthalmic Drug Delivery Device Sales Price by Country (2021-2026) & (USD/unit) Table 200. Europe Ophthalmic Drug Delivery Device Sales Price by Country (2027-2032) & (USD/unit) Table 201. Germany Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 202. France Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 203. U.K. Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 204. Italy Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 205. Russia Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 206. Spain Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 207. Netherlands Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 208. Switzerland Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 209. Sweden Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 210. Poland Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 211. China Ophthalmic Drug Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 212. China Ophthalmic Drug Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 213. China Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 214. China Ophthalmic Drug Delivery Device Sales by Type (2027-2032) & (k units) Table 215. China Ophthalmic Drug Delivery Device Sales Price by Type (2021-2026) & (USD/unit) Table 216. China Ophthalmic Drug Delivery Device Sales Price by Type (2027-2032) & (USD/unit) Table 217. China Ophthalmic Drug Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 218. China Ophthalmic Drug Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 219. China Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 220. China Ophthalmic Drug Delivery Device Sales by Application (2027-2032) & (k units) Table 221. China Ophthalmic Drug Delivery Device Sales Price by Application (2021-2026) & (USD/unit) Table 222. China Ophthalmic Drug Delivery Device Sales Price by Application (2027-2032) & (USD/unit) Table 223. Asia Ophthalmic Drug Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 224. Asia Ophthalmic Drug Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 225. Asia Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 226. Asia Ophthalmic Drug Delivery Device Sales by Type (2027-2032) & (k units) Table 227. Asia Ophthalmic Drug Delivery Device Sales Price by Type (2021-2026) & (USD/unit) Table 228. Asia Ophthalmic Drug Delivery Device Sales Price by Type (2027-2032) & (USD/unit) Table 229. Asia Ophthalmic Drug Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 230. Asia Ophthalmic Drug Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 231. Asia Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 232. Asia Ophthalmic Drug Delivery Device Sales by Application (2027-2032) & (k units) Table 233. Asia Ophthalmic Drug Delivery Device Sales Price by Application (2021-2026) & (USD/unit) Table 234. Asia Ophthalmic Drug Delivery Device Sales Price by Application (2027-2032) & (USD/unit) Table 235. Asia Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 236. Asia Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 237. Asia Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 238. Asia Ophthalmic Drug Delivery Device Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 239. Asia Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units) Table 240. Asia Ophthalmic Drug Delivery Device Sales by Country (2027-2032) & (k units) Table 241. Asia Ophthalmic Drug Delivery Device Sales Price by Country (2021-2026) & (USD/unit) Table 242. Asia Ophthalmic Drug Delivery Device Sales Price by Country (2027-2032) & (USD/unit) Table 243. Japan Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 244. South Korea Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 245. India Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 246. Australia Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 247. Taiwan Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 248. Southeast Asia Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 249. SAMEA Ophthalmic Drug Delivery Device Revenue by Type (2021-2026) & (US$ Million) Table 250. SAMEA Ophthalmic Drug Delivery Device Revenue by Type (2027-2032) & (US$ Million) Table 251. SAMEA Ophthalmic Drug Delivery Device Sales by Type (2021-2026) & (k units) Table 252. SAMEA Ophthalmic Drug Delivery Device Sales by Type (2027-2032) & (k units) Table 253. SAMEA Ophthalmic Drug Delivery Device Sales Price by Type (2021-2026) & (USD/unit) Table 254. SAMEA Ophthalmic Drug Delivery Device Sales Price by Type (2027-2032) & (USD/unit) Table 255. SAMEA Ophthalmic Drug Delivery Device Revenue by Application (2021-2026) & (US$ Million) Table 256. SAMEA Ophthalmic Drug Delivery Device Revenue by Application (2027-2032) & (US$ Million) Table 257. SAMEA Ophthalmic Drug Delivery Device Sales by Application (2021-2026) & (k units) Table 258. SAMEA Ophthalmic Drug Delivery Device Sales by Application (2027-2032) & (k units) Table 259. SAMEA Ophthalmic Drug Delivery Device Sales Price by Application (2021-2026) & (USD/unit) Table 260. SAMEA Ophthalmic Drug Delivery Device Sales Price by Application (2027-2032) & (USD/unit) Table 261. SAMEA Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 262. SAMEA Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 263. SAMEA Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 264. SAMEA Ophthalmic Drug Delivery Device Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 265. SAMEA Ophthalmic Drug Delivery Device Sales by Country (2021-2026) & (k units) Table 266. SAMEA Ophthalmic Drug Delivery Device Sales by Country (2027-2032) & (k units) Table 267. SAMEA Ophthalmic Drug Delivery Device Sales Price by Country (2021-2026) & (USD/unit) Table 268. SAMEA Ophthalmic Drug Delivery Device Sales Price by Country (2027-2032) & (USD/unit) Table 269. Brazil Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 270. Argentina Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 271. Chile Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 272. Colombia Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 273. Peru Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 274. Saudi Arabia Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 275. Israel Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 276. UAE Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 277. Turkey Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 278. Iran Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 279. Egypt Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Table 280. Key Raw Materials Table 281. Raw Materials Key Suppliers Table 282. Ophthalmic Drug Delivery Device Distributors List Table 283. Ophthalmic Drug Delivery Device Customers List Table 284. Research Programs/Design for This Report Table 285. Authors List of This Report Table 286. Secondary Sources Table 287. Primary Sources List of Figures Figure 1. Ophthalmic Drug Delivery Device Image Figure 2. Global Ophthalmic Drug Delivery Device Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Ophthalmic Drug Delivery Device Market Size Share 2021 VS 2025 VS 2032 Figure 4. Multidose Eyedroppers Image Figure 5. Add-On Devices Image Figure 6. Squeeze Dispenser Image Figure 7. Mist Sprayers Image Figure 8. Contact Lenses Image Figure 9. Pre-Filled Syringes Image Figure 10. Others Image Figure 11. Global Ophthalmic Drug Delivery Device Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Ophthalmic Drug Delivery Device Market Size Share 2021 VS 2025 VS 2032 Figure 13. Clinics Image Figure 14. Hospitals Image Figure 15. Homecare Image Figure 16. Others Image Figure 17. Global Ophthalmic Drug Delivery Device Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Ophthalmic Drug Delivery Device Revenue (2021-2032) & (US$ Million) Figure 19. Global Ophthalmic Drug Delivery Device Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 20. Global Ophthalmic Drug Delivery Device Revenue Market Share by Region: 2025 Versus 2032 Figure 21. Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2021-2032) Figure 22. Global Ophthalmic Drug Delivery Device Sales (2021-2032) & (k units) Figure 23. Global Ophthalmic Drug Delivery Device Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 24. Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2021-2032) Figure 25. US & Canada & Mexico Ophthalmic Drug Delivery Device Sales YoY (2021-2032) & (k units) Figure 26. Europe Ophthalmic Drug Delivery Device Sales YoY (2021-2032) & (k units) Figure 27. China Ophthalmic Drug Delivery Device Sales YoY (2021-2032) & (k units) Figure 28. Asia (Excluding China) Ophthalmic Drug Delivery Device Sales YoY (2021-2032) & (k units) Figure 29. South America, Middle East and Africa Ophthalmic Drug Delivery Device Sales YoY (2021-2032) & (k units) Figure 30. Global Ophthalmic Drug Delivery Device Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 31. Global Ophthalmic Drug Delivery Device Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 32. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 33. Global Ophthalmic Drug Delivery Device Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2021-2032) Figure 36. Global Ophthalmic Drug Delivery Device Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Ophthalmic Drug Delivery Device Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 38. Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2021-2032) Figure 39. Global Ophthalmic Drug Delivery Device Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 40. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2021-2032) Figure 42. Global Ophthalmic Drug Delivery Device Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 43. Global Ophthalmic Drug Delivery Device Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 44. Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2021-2032) Figure 45. North America Ophthalmic Drug Delivery Device Revenue Share by Type (2021-2032) Figure 46. North America Ophthalmic Drug Delivery Device Sales Share by Type (2021-2032) Figure 47. North America Ophthalmic Drug Delivery Device Revenue Share by Application (2021-2032) Figure 48. North America Ophthalmic Drug Delivery Device Sales Share by Application (2021-2032) Figure 49. North America Ophthalmic Drug Delivery Device Revenue Share by Country (2021-2032) Figure 50. North America Ophthalmic Drug Delivery Device Sales Share by Country (2021-2032) Figure 51. Europe Ophthalmic Drug Delivery Device Revenue Share by Type (2021-2032) Figure 52. Europe Ophthalmic Drug Delivery Device Sales Share by Type (2021-2032) Figure 53. Europe Ophthalmic Drug Delivery Device Revenue Share by Application (2021-2032) Figure 54. Europe Ophthalmic Drug Delivery Device Sales Share by Application (2021-2032) Figure 55. Europe Ophthalmic Drug Delivery Device Revenue Share by Country (2021-2032) Figure 56. Europe Ophthalmic Drug Delivery Device Sales Share by Country (2021-2032) Figure 57. China Ophthalmic Drug Delivery Device Revenue Share by Type (2021-2032) Figure 58. China Ophthalmic Drug Delivery Device Sales Share by Type (2021-2032) Figure 59. China Ophthalmic Drug Delivery Device Revenue Share by Application (2021-2032) Figure 60. China Ophthalmic Drug Delivery Device Sales Share by Application (2021-2032) Figure 61. Asia Ophthalmic Drug Delivery Device Revenue Share by Type (2021-2032) Figure 62. Asia Ophthalmic Drug Delivery Device Sales Share by Type (2021-2032) Figure 63. Asia Ophthalmic Drug Delivery Device Revenue Share by Application (2021-2032) Figure 64. Asia Ophthalmic Drug Delivery Device Sales Share by Application (2021-2032) Figure 65. Asia Ophthalmic Drug Delivery Device Revenue Share by Country (2021-2032) Figure 66. Asia Ophthalmic Drug Delivery Device Sales Share by Country (2021-2032) Figure 67. SAMEA Ophthalmic Drug Delivery Device Revenue Share by Type (2021-2032) Figure 68. SAMEA Ophthalmic Drug Delivery Device Sales Share by Type (2021-2032) Figure 69. SAMEA Ophthalmic Drug Delivery Device Revenue Share by Application (2021-2032) Figure 70. SAMEA Ophthalmic Drug Delivery Device Sales Share by Application (2021-2032) Figure 71. SAMEA Ophthalmic Drug Delivery Device Revenue Share by Country (2021-2032) Figure 72. SAMEA Ophthalmic Drug Delivery Device Sales Share by Country (2021-2032) Figure 73. Ophthalmic Drug Delivery Device Value Chain Figure 74. Manufacturing Cost Structure Figure 75. Ophthalmic Drug Delivery Device Production Mode & Process Figure 76. Direct Comparison with Distribution Share Figure 77. Distributors Profiles Figure 78. Years Considered Figure 79. Research Process Figure 80. Key Executives Interviewed

Scope & coverage.

Types
  • Multidose Eyedroppers
  • Add-On Devices
  • Squeeze Dispenser
  • Mist Sprayers
  • Contact Lenses
  • Pre-Filled Syringes
  • Others
Applications
  • Clinics
  • Hospitals
  • Homecare
  • Others
Companies covered
  • West Pharmaceutical Services, Inc.
  • Terumo Corporation
  • Silgan Holdings Inc.
  • Re-Vana Therapeutics
  • Owen Mumford
  • Ocumedic, Inc.
  • Ocular Therapeutix
  • Nipro Corporation
  • Nemera
  • Mati Therapeutics, Inc.,
  • Kedalion Therapeutics
  • Gerresheimer
  • Gaplast GmbH
  • EyePoint Pharmaceuticals, Inc.
  • Biocorp Production
  • Becton Dickinson & Company
  • Bausch Health
  • AptarGroup
  • Aero Pump GmbH

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Ophthalmic Drug Delivery Device Market by Type
  3. 1.2.1 Global Ophthalmic Drug Delivery Device Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Multidose Eyedroppers
  5. 1.2.3 Add-On Devices
  6. 1.2.4 Squeeze Dispenser
  7. 1.2.5 Mist Sprayers
  8. 1.2.6 Contact Lenses
  9. 1.2.7 Pre-Filled Syringes
  10. 1.2.8 Others
  11. 1.3 Ophthalmic Drug Delivery Device Market by Application
  12. 1.3.1 Global Ophthalmic Drug Delivery Device Market Size by Application, 2021 VS 2025 VS 2032
  13. 1.3.2 Clinics
  14. 1.3.3 Hospitals
  15. 1.3.4 Homecare
  16. 1.3.5 Others
  17. 1.4 Assumptions and Limitations
  18. 1.5 Study Goals and Objectives
2 Ophthalmic Drug Delivery Device Market Dynamics
  1. 2.1 Ophthalmic Drug Delivery Device Industry Trends
  2. 2.2 Ophthalmic Drug Delivery Device Industry Drivers
  3. 2.3 Ophthalmic Drug Delivery Device Industry Opportunities and Challenges
  4. 2.4 Ophthalmic Drug Delivery Device Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Ophthalmic Drug Delivery Device Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Ophthalmic Drug Delivery Device Revenue by Region
  3. 3.2.1 Global Ophthalmic Drug Delivery Device Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Ophthalmic Drug Delivery Device Revenue by Region (2021-2026)
  5. 3.2.3 Global Ophthalmic Drug Delivery Device Revenue by Region (2027-2032)
  6. 3.2.4 Global Ophthalmic Drug Delivery Device Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Ophthalmic Drug Delivery Device Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Ophthalmic Drug Delivery Device Sales by Region
  9. 3.4.1 Global Ophthalmic Drug Delivery Device Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Ophthalmic Drug Delivery Device Sales by Region (2021-2026)
  11. 3.4.3 Global Ophthalmic Drug Delivery Device Sales by Region (2027-2032)
  12. 3.4.4 Global Ophthalmic Drug Delivery Device Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Ophthalmic Drug Delivery Device Revenue by Manufacturers
  2. 4.1.1 Global Ophthalmic Drug Delivery Device Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Ophthalmic Drug Delivery Device Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Ophthalmic Drug Delivery Device Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Ophthalmic Drug Delivery Device Sales by Manufacturers
  6. 4.2.1 Global Ophthalmic Drug Delivery Device Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Ophthalmic Drug Delivery Device Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Ophthalmic Drug Delivery Device Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Ophthalmic Drug Delivery Device Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Ophthalmic Drug Delivery Device Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Ophthalmic Drug Delivery Device Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Ophthalmic Drug Delivery Device Manufacturers, Product Type & Application
  13. 4.7 Global Ophthalmic Drug Delivery Device Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Ophthalmic Drug Delivery Device Market CR5 and HHI
  16. 4.8.2 2025 Ophthalmic Drug Delivery Device Tier 1, Tier 2, and Tier 3
5 Ophthalmic Drug Delivery Device Market by Type
  1. 5.1 Global Ophthalmic Drug Delivery Device Revenue by Type
  2. 5.1.1 Global Ophthalmic Drug Delivery Device Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Ophthalmic Drug Delivery Device Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Ophthalmic Drug Delivery Device Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Ophthalmic Drug Delivery Device Sales by Type
  6. 5.2.1 Global Ophthalmic Drug Delivery Device Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Ophthalmic Drug Delivery Device Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Ophthalmic Drug Delivery Device Sales Market Share by Type (2021-2032)
  9. 5.3 Global Ophthalmic Drug Delivery Device Price by Type
6 Ophthalmic Drug Delivery Device Market by Application
  1. 6.1 Global Ophthalmic Drug Delivery Device Revenue by Application
  2. 6.1.1 Global Ophthalmic Drug Delivery Device Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Ophthalmic Drug Delivery Device Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Ophthalmic Drug Delivery Device Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Ophthalmic Drug Delivery Device Sales by Application
  6. 6.2.1 Global Ophthalmic Drug Delivery Device Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Ophthalmic Drug Delivery Device Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Ophthalmic Drug Delivery Device Sales Market Share by Application (2021-2032)
  9. 6.3 Global Ophthalmic Drug Delivery Device Price by Application
7 Company Profiles
  1. 7.1 West Pharmaceutical Services, Inc.
  2. 7.1.1 West Pharmaceutical Services, Inc. Company Information
  3. 7.1.2 West Pharmaceutical Services, Inc. Business Overview
  4. 7.1.3 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 West Pharmaceutical Services, Inc. Ophthalmic Drug Delivery Device Product Portfolio
  6. 7.1.5 West Pharmaceutical Services, Inc. Recent Developments
  7. 7.2 Terumo Corporation
  8. 7.2.1 Terumo Corporation Company Information
  9. 7.2.2 Terumo Corporation Business Overview
  10. 7.2.3 Terumo Corporation Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Terumo Corporation Ophthalmic Drug Delivery Device Product Portfolio
  12. 7.2.5 Terumo Corporation Recent Developments
  13. 7.3 Silgan Holdings Inc.
  14. 7.3.1 Silgan Holdings Inc. Company Information
  15. 7.3.2 Silgan Holdings Inc. Business Overview
  16. 7.3.3 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Silgan Holdings Inc. Ophthalmic Drug Delivery Device Product Portfolio
  18. 7.3.5 Silgan Holdings Inc. Recent Developments
  19. 7.4 Re-Vana Therapeutics
  20. 7.4.1 Re-Vana Therapeutics Company Information
  21. 7.4.2 Re-Vana Therapeutics Business Overview
  22. 7.4.3 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Re-Vana Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
  24. 7.4.5 Re-Vana Therapeutics Recent Developments
  25. 7.5 Owen Mumford
  26. 7.5.1 Owen Mumford Company Information
  27. 7.5.2 Owen Mumford Business Overview
  28. 7.5.3 Owen Mumford Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Owen Mumford Ophthalmic Drug Delivery Device Product Portfolio
  30. 7.5.5 Owen Mumford Recent Developments
  31. 7.6 Ocumedic, Inc.
  32. 7.6.1 Ocumedic, Inc. Company Information
  33. 7.6.2 Ocumedic, Inc. Business Overview
  34. 7.6.3 Ocumedic, Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Ocumedic, Inc. Ophthalmic Drug Delivery Device Product Portfolio
  36. 7.6.5 Ocumedic, Inc. Recent Developments
  37. 7.7 Ocular Therapeutix
  38. 7.7.1 Ocular Therapeutix Company Information
  39. 7.7.2 Ocular Therapeutix Business Overview
  40. 7.7.3 Ocular Therapeutix Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Ocular Therapeutix Ophthalmic Drug Delivery Device Product Portfolio
  42. 7.7.5 Ocular Therapeutix Recent Developments
  43. 7.8 Nipro Corporation
  44. 7.8.1 Nipro Corporation Company Information
  45. 7.8.2 Nipro Corporation Business Overview
  46. 7.8.3 Nipro Corporation Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Nipro Corporation Ophthalmic Drug Delivery Device Product Portfolio
  48. 7.8.5 Nipro Corporation Recent Developments
  49. 7.9 Nemera
  50. 7.9.1 Nemera Company Information
  51. 7.9.2 Nemera Business Overview
  52. 7.9.3 Nemera Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Nemera Ophthalmic Drug Delivery Device Product Portfolio
  54. 7.9.5 Nemera Recent Developments
  55. 7.10 Mati Therapeutics, Inc.,
  56. 7.10.1 Mati Therapeutics, Inc., Company Information
  57. 7.10.2 Mati Therapeutics, Inc., Business Overview
  58. 7.10.3 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Mati Therapeutics, Inc., Ophthalmic Drug Delivery Device Product Portfolio
  60. 7.10.5 Mati Therapeutics, Inc., Recent Developments
  61. 7.11 Kedalion Therapeutics
  62. 7.11.1 Kedalion Therapeutics Company Information
  63. 7.11.2 Kedalion Therapeutics Business Overview
  64. 7.11.3 Kedalion Therapeutics Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Kedalion Therapeutics Ophthalmic Drug Delivery Device Product Portfolio
  66. 7.11.5 Kedalion Therapeutics Recent Developments
  67. 7.12 Gerresheimer
  68. 7.12.1 Gerresheimer Company Information
  69. 7.12.2 Gerresheimer Business Overview
  70. 7.12.3 Gerresheimer Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Gerresheimer Ophthalmic Drug Delivery Device Product Portfolio
  72. 7.12.5 Gerresheimer Recent Developments
  73. 7.13 Gaplast GmbH
  74. 7.13.1 Gaplast GmbH Company Information
  75. 7.13.2 Gaplast GmbH Business Overview
  76. 7.13.3 Gaplast GmbH Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Gaplast GmbH Ophthalmic Drug Delivery Device Product Portfolio
  78. 7.13.5 Gaplast GmbH Recent Developments
  79. 7.14 EyePoint Pharmaceuticals, Inc.
  80. 7.14.1 EyePoint Pharmaceuticals, Inc. Company Information
  81. 7.14.2 EyePoint Pharmaceuticals, Inc. Business Overview
  82. 7.14.3 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 EyePoint Pharmaceuticals, Inc. Ophthalmic Drug Delivery Device Product Portfolio
  84. 7.14.5 EyePoint Pharmaceuticals, Inc. Recent Developments
  85. 7.15 Biocorp Production
  86. 7.15.1 Biocorp Production Company Information
  87. 7.15.2 Biocorp Production Business Overview
  88. 7.15.3 Biocorp Production Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Biocorp Production Ophthalmic Drug Delivery Device Product Portfolio
  90. 7.15.5 Biocorp Production Recent Developments
  91. 7.16 Becton Dickinson & Company
  92. 7.16.1 Becton Dickinson & Company Company Information
  93. 7.16.2 Becton Dickinson & Company Business Overview
  94. 7.16.3 Becton Dickinson & Company Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Becton Dickinson & Company Ophthalmic Drug Delivery Device Product Portfolio
  96. 7.16.5 Becton Dickinson & Company Recent Developments
  97. 7.17 Bausch Health
  98. 7.17.1 Bausch Health Company Information
  99. 7.17.2 Bausch Health Business Overview
  100. 7.17.3 Bausch Health Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Bausch Health Ophthalmic Drug Delivery Device Product Portfolio
  102. 7.17.5 Bausch Health Recent Developments
  103. 7.18 AptarGroup
  104. 7.18.1 AptarGroup Company Information
  105. 7.18.2 AptarGroup Business Overview
  106. 7.18.3 AptarGroup Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 AptarGroup Ophthalmic Drug Delivery Device Product Portfolio
  108. 7.18.5 AptarGroup Recent Developments
  109. 7.19 Aero Pump GmbH
  110. 7.19.1 Aero Pump GmbH Company Information
  111. 7.19.2 Aero Pump GmbH Business Overview
  112. 7.19.3 Aero Pump GmbH Ophthalmic Drug Delivery Device Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Aero Pump GmbH Ophthalmic Drug Delivery Device Product Portfolio
  114. 7.19.5 Aero Pump GmbH Recent Developments
8 North America
  1. 8.1 North America Ophthalmic Drug Delivery Device Market Size by Type
  2. 8.1.1 North America Ophthalmic Drug Delivery Device Revenue by Type (2021-2032)
  3. 8.1.2 North America Ophthalmic Drug Delivery Device Sales by Type (2021-2032)
  4. 8.1.3 North America Ophthalmic Drug Delivery Device Price by Type (2021-2032)
  5. 8.2 North America Ophthalmic Drug Delivery Device Market Size by Application
  6. 8.2.1 North America Ophthalmic Drug Delivery Device Revenue by Application (2021-2032)
  7. 8.2.2 North America Ophthalmic Drug Delivery Device Sales by Application (2021-2032)
  8. 8.2.3 North America Ophthalmic Drug Delivery Device Price by Application (2021-2032)
  9. 8.3 North America Ophthalmic Drug Delivery Device Market Size by Country
  10. 8.3.1 North America Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Ophthalmic Drug Delivery Device Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Ophthalmic Drug Delivery Device Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Ophthalmic Drug Delivery Device Market Size by Type
  2. 9.1.1 Europe Ophthalmic Drug Delivery Device Revenue by Type (2021-2032)
  3. 9.1.2 Europe Ophthalmic Drug Delivery Device Sales by Type (2021-2032)
  4. 9.1.3 Europe Ophthalmic Drug Delivery Device Price by Type (2021-2032)
  5. 9.2 Europe Ophthalmic Drug Delivery Device Market Size by Application
  6. 9.2.1 Europe Ophthalmic Drug Delivery Device Revenue by Application (2021-2032)
  7. 9.2.2 Europe Ophthalmic Drug Delivery Device Sales by Application (2021-2032)
  8. 9.2.3 Europe Ophthalmic Drug Delivery Device Price by Application (2021-2032)
  9. 9.3 Europe Ophthalmic Drug Delivery Device Market Size by Country
  10. 9.3.1 Europe Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Ophthalmic Drug Delivery Device Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Ophthalmic Drug Delivery Device Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Ophthalmic Drug Delivery Device Market Size by Type
  2. 10.1.1 China Ophthalmic Drug Delivery Device Revenue by Type (2021-2032)
  3. 10.1.2 China Ophthalmic Drug Delivery Device Sales by Type (2021-2032)
  4. 10.1.3 China Ophthalmic Drug Delivery Device Price by Type (2021-2032)
  5. 10.2 China Ophthalmic Drug Delivery Device Market Size by Application
  6. 10.2.1 China Ophthalmic Drug Delivery Device Revenue by Application (2021-2032)
  7. 10.2.2 China Ophthalmic Drug Delivery Device Sales by Application (2021-2032)
  8. 10.2.3 China Ophthalmic Drug Delivery Device Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Ophthalmic Drug Delivery Device Market Size by Type
  2. 11.1.1 Asia Ophthalmic Drug Delivery Device Revenue by Type (2021-2032)
  3. 11.1.2 Asia Ophthalmic Drug Delivery Device Sales by Type (2021-2032)
  4. 11.1.3 Asia Ophthalmic Drug Delivery Device Price by Type (2021-2032)
  5. 11.2 Asia Ophthalmic Drug Delivery Device Market Size by Application
  6. 11.2.1 Asia Ophthalmic Drug Delivery Device Revenue by Application (2021-2032)
  7. 11.2.2 Asia Ophthalmic Drug Delivery Device Sales by Application (2021-2032)
  8. 11.2.3 Asia Ophthalmic Drug Delivery Device Price by Application (2021-2032)
  9. 11.3 Asia Ophthalmic Drug Delivery Device Market Size by Country
  10. 11.3.1 Asia Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Ophthalmic Drug Delivery Device Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Ophthalmic Drug Delivery Device Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Ophthalmic Drug Delivery Device Market Size by Type
  2. 12.1.1 SAMEA Ophthalmic Drug Delivery Device Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Ophthalmic Drug Delivery Device Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Ophthalmic Drug Delivery Device Price by Type (2021-2032)
  5. 12.2 SAMEA Ophthalmic Drug Delivery Device Market Size by Application
  6. 12.2.1 SAMEA Ophthalmic Drug Delivery Device Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Ophthalmic Drug Delivery Device Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Ophthalmic Drug Delivery Device Price by Application (2021-2032)
  9. 12.3 SAMEA Ophthalmic Drug Delivery Device Market Size by Country
  10. 12.3.1 SAMEA Ophthalmic Drug Delivery Device Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Ophthalmic Drug Delivery Device Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Ophthalmic Drug Delivery Device Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Ophthalmic Drug Delivery Device Value Chain Analysis
  2. 13.1.1 Ophthalmic Drug Delivery Device Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Ophthalmic Drug Delivery Device Production Mode & Process
  6. 13.2 Ophthalmic Drug Delivery Device Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Ophthalmic Drug Delivery Device Distributors
  9. 13.2.3 Ophthalmic Drug Delivery Device Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst